MGC Diagnostics Corporation Overview
Company Headquarters: Minnesota, US
Founded: 1986
Workforce: 215
Company Working: MGC Diagnostics Corporation creates, produces, and markets non-invasive diagnostic tools for the detection, management, and treatment of cardiorespiratory disease. It provides cardiovascular exercise systems, pulmonary function testing equipment, flow sensors, gas analyzers, spirometers, and related consumables. The company's products have applications in figuring out the right nutritional support needs, evaluating the effectiveness of prescription medications, and using diagnostics to look for early indications of cardiac and pulmonary failure. Through a direct sales force and distributors, it offers its products under the MGC diagnostics and Medisoft brand names to hospitals, university-based medical centers, organizations, clinics, doctor's offices, pharmaceutical firms, medical device producers, and clinical research organizations. Additionally, the business works as a division of CAIRE, Inc. (US). Furthermore, the company has operations in the US, Belgium, France, Australia, and Germany.
Strategy
MGC Diagnostics Corporation focused on creating effective and precise tools to help with respiratory disease diagnosis, making sure the data obtained is useful for the disease management process. It also aims to incorporate the most recent technological advancements available currently, guarantee correctness through excellent design, and then support each and every product with continuously outstanding support. It also focuses on enhancing currently offered products on the market. Furthermore, it emphasizes boosting FDA clearances for introducing new products and entering untapped markets.
